SCHEMBL23715992

SCHEMBL23715992

Bc1cnc(Cc2ccc(Cl)c(F)c2)c(C)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 1/20 0.33
P2RX7 Q99572 1/20 0.33
PARP1 P09874 2/20 0.32
KCNH2 Q12809 1/20 0.32
FPR2 P25090 2/20 0.32
PROKR1 Q8TCW9 2/20 0.32
ANO1 Q5XXA6 1/20 0.32
KDM5A P29375 1/20 0.32
KDM5B Q9UGL1 1/20 0.32
GRM2 Q14416 1/20 0.32
AKT1 P31749 1/20 0.31
QPCT Q16769 2/20 0.31
KDM4E B2RXH2 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C19 P33261 1/20 0.31
HIF1A Q16665 1/20 0.31
QPCTL Q9NXS2 1/20 0.31
AGBL2 Q5U5Z8 1/20 0.31
GPR52 Q9Y2T5 1/20 0.31
PDE2A O00408 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17664039 0.87 RAPGEF4 (0.40) RAPGEF4P2RX7PARP1KCNH2FPR2
SCHEMBL17664049 0.87 PARP1 (0.35) RAPGEF4P2RX7PARP1KCNH2FPR2
SCHEMBL17664035 0.84 S1PR1 (0.38) RAPGEF4P2RX7PARP1KCNH2FPR2
SCHEMBL23716252 0.79 RAPGEF4 (0.35) RAPGEF4P2RX7PARP1KCNH2FPR2
SCHEMBL17664085 0.76 PARP1 (0.37) PARP1GRM2QPCTQPCTLGPR52
SCHEMBL23716095 0.75 GPR52 (0.34) ANO1KDM5AKDM5BGRM2AKT1
SCHEMBL17664040 0.71 NPC1 (0.37) RAPGEF4KCNH2CYP2C19GPR52
SCHEMBL17664034 0.71 TSHR (0.42) KCNH2MAPK1
SCHEMBL21384047 0.70 CYP3A4 (0.42) GRM2QPCTCYP3A4QPCTLGPR52
SCHEMBL17664392 0.70 PARP1 (0.45) P2RX7PARP1ANO1KDM5AKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3209732-B1 SPHINGOSINE-1-PHOSPATE RECEPTOR MODULATORS FOR TREATMENT OF CARDIOPULMONARY DISORDERS SCRIPPS RESEARCH INST (US) 2021-08-04 EP disclosed